FDAFDA · Food and drugs·Recall number D-184-2013
HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54
Published March 13, 2013 · Recall initiated: October 22, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- HEXTEND
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot # 10-199-JT Exp. 10/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.